Journal
JOURNAL OF VIROLOGY
Volume 88, Issue 6, Pages 3485-3495Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.02649-13
Keywords
-
Categories
Funding
- CIHR
- Ontario Graduate Scholarship Award
- NIH [CA77816, CA155566]
Ask authors/readers for more resources
An effective type I interferon (IFN)-mediated immune response requires the rapid expression of antiviral proteins that are necessary to inhibit viral replication and virus spread. We provide evidence that IFN-beta regulates metabolic events important for the induction of a rapid antiviral response: IFN-beta decreases the phosphorylation of AMP-activated protein kinase (AMPK), coincident with an increase in intracellular ATP. Our studies reveal a biphasic IFN-beta-inducible uptake of glucose by cells, mediated by phosphatidylinositol 3-kinase (PI3K)/Akt, and IFN-beta-inducible regulation of GLUT4 translocation to the cell surface. Additionally, we provide evidence that IFN-beta-regulated glycolytic metabolism is important for the acute induction of an antiviral response during infection with coxsackievirus B3 (CVB3). Last, we demonstrate that the antidiabetic drug metformin enhances the antiviral potency of IFN-beta against CVB3 both in vitro and in vivo. Taken together, these findings highlight an important role for IFN-beta in modulating glucose metabolism during a virus infection and suggest that the use of metformin in combination with IFN-beta during acute virus infection may result in enhanced antiviral responses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available